Alliancebernstein L.P. Esperion Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 279,760 shares of ESPR stock, worth $794,518. This represents 0.0% of its overall portfolio holdings.

Number of Shares

279,760

Previous 159,260 75.66%

Holding current value

$794,518

Previous $229,000 19.65%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.73 - $1.41 $87,965 - $169,905	120,500 Added 75.66%	279,760 $274,000
Q4 2024 Feb 12, 2025	SELL	$1.61 - $3.83 $36,788 - $87,515	-22,850 Reduced 12.55%	159,260 $350,000
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $335,082 - $590,036	182,110 New	182,110 $404,000
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $26,864 - $134,320	18,400 Added 33.7%	73,000 $116,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $59,283 - $98,999	11,647 Added 27.12%	54,600 $340,000
Q3 2022 Nov 15, 2022	BUY	$5.45 - $8.13 $33,533 - $50,023	6,153 Added 16.72%	42,953 $288,000
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $40,545 - $56,695	8,500 Added 30.04%	36,800 $234,000
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $1,298 - $3,218	-270 Reduced 0.95%	28,300 $142,000
Q2 2021 Jul 30, 2021	BUY	$19.4 - $28.71 $93,120 - $137,808	4,800 Added 20.19%	28,570 $604,000
Q1 2021 May 06, 2021	SELL	$25.12 - $36.89 $158,256 - $232,407	-6,300 Reduced 20.95%	23,770 $667,000
Q3 2020 Nov 12, 2020	SELL	$31.18 - $52.71 $193,316 - $326,802	-6,200 Reduced 17.09%	30,070 $1.12 Million
Q2 2020 Aug 13, 2020	BUY	$30.04 - $51.31 $99,132 - $169,323	3,300 Added 10.01%	36,270 $1.86 Million
Q4 2019 Feb 18, 2020	SELL	$35.4 - $59.82 $1.04 Million - $1.76 Million	-29,494 Reduced 47.22%	32,970 $1.97 Million
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $1.4 Million - $1.83 Million	34,894 Added 126.57%	62,464 $2.91 Million
Q4 2018 Feb 13, 2019	SELL	$36.99 - $59.11 $270,027 - $431,503	-7,300 Reduced 20.93%	27,570 $1.27 Million
Q2 2018 Aug 13, 2018	BUY	$36.2 - $76.4 $166,520 - $351,440	4,600 Added 15.2%	34,870 $1.37 Million
Q1 2018 May 14, 2018	SELL	$65.94 - $80.76 $309,918 - $379,572	-4,700 Reduced 13.44%	30,270 $2.19 Million
Q4 2017 Feb 13, 2018	BUY	$43.47 - $67.43 $434,700 - $674,300	10,000 Added 40.05%	34,970 $2.3 Million
Q3 2017 Nov 13, 2017	BUY	$43.8 - $52.77 $1.09 Million - $1.32 Million	24,970	24,970 $1.25 Million

Others Institutions Holding ESPR

# of Institutions

185

Shares Held

109M

Call Options Held

139K

Put Options Held

604K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $189M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Esperion Therapeutics, Inc. Transaction History